SpeeDx included in new PHE National Microbiology Framework
SpeeDx has been included in the new Public Health England (PHE) National Microbiology Framework to supply Diagnostic goods and services across the UK.
Under Lot 1 of the framework, participating public health authorities can access in-vitro diagnostics (IVDs) and associated services from SpeeDx. Offerings include the recently launched CE-IVD PlexPCR® SARS-COV-2 – a dual-target molecular assay to aid in the diagnosis of COVID-19. The non-exclusive agreement streamlines laboratory access to key suppliers and allows for easier access to SpeeDx products to support the UK plan of building resilience in diagnostic supply chains.
Read the full press release